LOUISVILLE, Ky. (WAVE) - Three sisters are questioning their father’s death, just days after he entered the care of a Southern Indiana nursing home. After just two days in the Waters of Clifty Falls ...
Originally for diabetes, drugs like Ozempic and Mounjaro are now popular for weight loss but experts warn of risks. These ...
Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of ...
13don MSN
Myth versus fact: What we know about the risks and side effects of the new weight-loss drugs
Pancreatitis, vision loss ... the risks of drugs such as Ozempic can sound scary. But what does the evidence show?
An AI tool showed noninferiority to senior endocrinology physicians in insulin titration for hospitalized patients with type 2 diabetes. About 99% of AI-based insulin recommendations were adopted by ...
Many doctors and patients came to believe the rise in obesity may be all but biologically inescapable, despite the grave ...
Arising from: Marks JB (2008) How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus? Nat Clin Pract ...
Pre-diabetes offers a crucial chance to reset metabolism and prevent full diabetes. Longevity doctor Dr. Vassily Eliopoulos ...
Icovamenib showed a sustained treatment benefit at Week 52 (9 months past the end of treatment) in the severe insulin-deficient diabetes patient population taking one or more antihyperglycemic ...
Artificial intelligence (AI) is steadily reshaping diabetes care, from diagnostic advances to providing new tools that lighten patients’ daily management burden, according to experts in the field.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results